Dermata Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.23

+0.00 (+0.00%)

As of May 16, 2:33 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,052.8% upside

Low Target $26.82

Average Target $38.78

High Target $44.92

Current Price $1.23

Current
$1.23

Target
$38.78

$26.82 $38.78 avg $44.92

Scenario Analysis

Bear Case

$26.82

2,080.5%

Low target

Base Case

$38.78

+3,052.8%

Avg target

Bull Case

$44.92

+3,552.0%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$8.50

-85.5% from high

52-Week Low

$1.10

+11.8% from low

Target vs 52W High

$38.78

+356.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%